Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes

Abstract

In this population of gastric cancer surgical patients, the prevalence of sarcopenia was 57.7%, which is high compared to other abdominal surgical oncology populations. However, sarcopenia was not associated with postoperative morbidity or mortality.